DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Magnevist (Gadopentetate Dimeglumine) - Published Studies

 
 



Magnevist Related Published Studies

Well-designed clinical trials related to Magnevist (Gadopentetate)

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial). [2011.02]

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. [2010.06]

Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. [2009.10]

Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla. [2009.04]

Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. [2009.03]

Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla. [2008.10]

Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention. [2007.04]

Well-designed clinical trials possibly related to Magnevist (Gadopentetate)

Blind or ultrasound-guided corticosteroid injections and short-term response in subacromial impingement syndrome: a randomized, double-blind, prospective study. [2012]

Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging. [2011.07]

Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. [2011.04]

Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study. [2011.03.17]

Noninvasive evaluation of endolymphatic space in healthy volunteers using magnetic resonance imaging. [2011.03]

Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP). [2011.02]

Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. [2011]

Prospective comparison of image quality and diagnostic accuracy of 0.5 molar gadobenate dimeglumine and 1.0 molar gadobutrol in contrast-enhanced run-off magnetic resonance angiography of the lower extremities. [2010.11]

Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. [2010.07.01]

Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. [2010.07]

Comparison of gadobenate dimeglumine and gadodiamide in the evaluation of spinal vascular anatomy with MR angiography. [2010.06]

Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1. [2010.05]

Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. [2010.02.13]

Comparison of gadodiamide-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: results of a phase III multicenter trial. [2010.02]

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. [2010.02]

Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease. [2010.01.25]

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. [2010]

Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement. [2009.09]

Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study. [2009.06]

Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI. [2009.06]

First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia. [2009.02]

Intra-articular distribution pattern after ultrasound-guided injections in wrist joints of patients with rheumatoid arthritis. [2009.02]

Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI. [2009.01]

Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA. [2009.01]

Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. [2009.01]

Low injection rate for 3D moving-table bolus-chase MR angiography: initial experience with 3-T imaging to allay venous contamination in the calf. [2008.12]

Longitudinal evaluation of cartilage composition of matrix-associated autologous chondrocyte transplants with 3-T delayed gadolinium-enhanced MRI of cartilage. [2008.11]

Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. [2008.11]

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. [2008.11]

Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. [2008.10.01]

Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide. [2008.10]

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. [2008.07]

MR colonography with fecal tagging: barium vs. barium ferumoxsil. [2008.05]

Rapid multiplanar abdominal survey using MRI with the steady-state free-precession technique. [2008.01]

Magnetic resonance imaging of hindfoot involvement in patients with spondyloarthritides: comparison of low-field and high-field strength units. [2008.01]

Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II study. [2007.12]

Injection of the subacromial-subdeltoid bursa: blind or ultrasound-guided? [2007.04]

Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. [2007.04]

Dose comparison of single- vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA. [2007.03]

A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. [2007.03]

The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography. [2007.03]

Other research related to Magnevist (Gadopentetate)

Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine. [2011.04.06]

Interstitial MR lymphography in mice with gadopentetate dimeglumine and gadoxetate disodium. [2011.02]

Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. [2011.02]

A review of preclinical safety data for magnevist (gadopentetate dimeglumine) in the context of nephrogenic systemic fibrosis. [2010.09]

Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine. [2010.06]

Neurotoxic manifestations of an overdose intrathecal injection of gadopentetate dimeglumine. [2010.03]

Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T. [2010.03]

Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. [2010.02]

Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients. [2009.10]

Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla. [2009.06]

Left ventricular infarct size assessed with 0.1 mmol/kg of gadobenate dimeglumine correlates with that assessed with 0.2 mmol/kg of gadopentetate dimeglumine. [2009.05]

Other possibly related research studies

Do patients with structural abnormalities of the shoulder experience pain after MR arthrography of the shoulder? [2010.09]

Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. [2010.09]

Cervical myelopathy from spinal sarcoidosis as the unexpected initial presentation for systemic sarcoidosis. [2010.09]

Rheumatoid arthritis of the hand: monitoring with a simplified MR imaging scoring method--preliminary assessment. [2010.09]

Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid. [2010.08]

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. [2010.07.13]

Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. [2010.11]

Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR. [2010.06]

Cerebral angiography using gadolinium as an alternative contrast medium in a patient with severe allergy to iodinated contrast medium. [2010.03]

Whole-body MR imaging versus sequential multimodal diagnostic algorithm for staging patients with rectal cancer: cost analysis. [2010.09]

Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. [2010.08]

Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial. [2010.06]

Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery. [2010.05.13]

An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. [2010.05]

Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? [2010.05]

Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. [2010.05]

Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. [2010.05]

Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. [2010.07]

Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study. [2010.05]

Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. [2010.04.20]

Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: comparison at cardiac MR imaging. [2010.06]

Diagnostics and treatment of spontaneous intracranial hypotension. [2010.02]

Systolic 3D first-pass myocardial perfusion MRI: Comparison with diastolic imaging in healthy subjects. [2010.04]

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy. [2010.03]

Self-assembly of SiO2/Gd-DTPA-polyethylenimine nanocomposites as magnetic resonance imaging probes. [2010.01]

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. [2010.05]

Gadoxetate disodium-enhanced magnetic resonance cholangiography for the noninvasive detection of an active bile duct leak after laparoscopic cholecystectomy. [2010.03]

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. [2010.03]

MRI of the cat brain in the study of vascular permeability after intraarterial carotid injection of triolein. [2010.06]

MR imaging of the cochlear modiolus after intratympanic administration of Gd-DTPA. [2010]

Estimation of gadolinium-induced T1-shortening with measurement of simple signal intensity ratio between the cochlea and brain parenchyma on 3D-FLAIR: correlation with T1 measurement by TI scout sequence. [2010]

Effective aerosol delivery during high-frequency ventilation in neonatal pigs. [2010.04]

Reversible leukoencephalopathy syndrome. [2010.03]

[Optimized use of cross-sectional imaging for the early diagnosis and management of ankylosing spondyloarthropathy] [2010.01]

[Cross-sectional imaging of peripheral involvement in ankylosing spondylitis] [2010.01]

[MR imaging of the hands in rheumatoid arthritis] [2010.01]

Delayed gadolinium-enhanced MRI of cartilage in the ankle at 3 T: feasibility and preliminary results after matrix-associated autologous chondrocyte implantation. [2010.03]

Restrictive right ventricular physiology and right ventricular fibrosis as assessed by cardiac magnetic resonance and exercise capacity after biventricular repair of pulmonary atresia and intact ventricular septum. [2010.02]

Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate. [2010.03]

Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla. [2010.05]

Evaluation of rHA labeled with Gd-DTPA for blood pool imaging and targeted contrast delivery. [2010.01]

[Spontaneous intracranial hypotension with extensive epidural fluid collection in the spine: a case improved with steroid therapy] [2010.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012